3D-CEUS/MRI–CEUS fusion imaging vs 2D-CEUS after locoregional therapies for hepatocellular carcinoma: a multicenter prospective study of therapeutic response evaluation-Reference-Cited by-同舟云学术

3D-CEUS/MRI–CEUS fusion imaging vs 2D-CEUS after locoregional therapies for hepatocellular carcinoma: a multicenter prospective study of therapeutic response evaluation

Published:2024-07-11 Issue: Volume: Page:
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Wang Feihang,Zhang Qi,Yan Kun,Jing Xiang,Chen Yaqing,Kong Wentao,Zhao Qiyu,Zhu Zheng,Dong Yi,Wang Wenping^ORCID

Funder

National Natural Science Foundation of China

the Sino-German Mobility Programme of NSFC and DFG

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00330-024-10915-0.pdf

Reference30 articles.

1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

2. Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S (2015) Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 261:947–955

3. Zhou J, Sun H, Wang Z et al (2023) Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition). Liver Cancer 12:405–444

4. Li FY, Li JG, Wu SS et al (2021) An optimal ablative margin of small single hepatocellular carcinoma treated with image-guided percutaneous thermal ablation and local recurrence prediction base on the ablative margin: a multicenter study. J Hepatocell Carcinoma 8:1375–1388

5. Polikoff A, Wessner CE, Balasubramanya R et al (2022) Imaging appearance of residual HCC following incomplete trans-arterial chemoembolization on contrast-enhanced imaging. Abdom Radiol (NY) 47:152–160